New Belly-Delivered insulin put to the test in early trial
Knowledge-focused
Recruiting now
This early-stage study is testing a new concentrated insulin (U-500) given into the belly cavity in 25 adults with Type 1 Diabetes. The goal is to see if it is safe and how fast the body absorbs and uses it. Participants will have their blood sugar kept steady for 12 hours after …
Phase: PHASE1 • Sponsor: Portal Diabetes, Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC